China National Accord Medicines (SZSE:000028) 3-Year Book Growth Rate : 7.70% (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines 3-Year Book Growth Rate?

China National Accord Medicines's Book Value per Share for the quarter that ended in Mar. 2024 was ¥31.99.

During the past 12 months, China National Accord Medicines's average Book Value per Share Growth Rate was 8.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 7.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 8.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of China National Accord Medicines was 48.70% per year. The lowest was -3.10% per year. And the median was 8.85% per year.

Competitive Comparison of China National Accord Medicines's 3-Year Book Growth Rate

For the Medical Distribution subindustry, China National Accord Medicines's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines's 3-Year Book Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's 3-Year Book Growth Rate falls into.

China National Accord Medicines 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

China National Accord Medicines (SZSE:000028) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

China National Accord Medicines 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines